Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HROW Harrow Health Inc
- Stocks
- Healthcare
- NASDAQ: HROW
Price (delayed)
$29.51
Market cap
$1.08B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.61
Enterprise value
$1.25B
Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton
Highlights
HROW's gross profit has soared by 64% YoY and by 6% QoQ
HROW's revenue has surged by 53% year-on-year and by 7% since the previous quarter
The EPS rose by 34% year-on-year but it has declined by 24% since the previous quarter
Harrow Health's net income has increased by 31% YoY but it has decreased by 24% from the previous quarter
Harrow Health's quick ratio has plunged by 69% YoY and by 57% from the previous quarter
Harrow Health's debt has increased by 20% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.harrowinc.com
Key stats
What are the main financial stats of HROW
Market
Valuations
Earnings
Shares outstanding
36.7M
Market cap
$1.08B
Enterprise value
$1.25B
Price to earnings (P/E)
N/A
Price to book (P/B)
18.64
Price to sales (P/S)
4.97
EV/EBIT
522.77
EV/EBITDA
66.83
EV/Sales
5.86
Revenue
$212.86M
Gross profit
$158.64M
Operating income
$4.52M
Net income
-$21.7M
EBIT
$2.38M
EBITDA
$18.65M
Free cash flow
$421,000
Per share
Balance sheet
Liquidity
EPS
-$0.61
EPS diluted
-$0.61
Free cash flow per share
$0.01
Book value per share
$1.58
Revenue per share
$5.94
TBVPS
$5.06
Total assets
$364.16M
Total liabilities
$308.07M
Debt
$230.01M
Equity
$56.45M
Working capital
-$17.45M
Debt to equity
4.07
Current ratio
0.91
Quick ratio
0.77
Net debt/EBITDA
8.76
Margins
Efficiency
Dividend
EBITDA margin
8.8%
Gross margin
74.5%
Net margin
-10.2%
Operating margin
2.1%
Return on assets
-6.1%
Return on equity
-35.8%
Return on invested capital
1.1%
Return on capital employed
1.3%
Return on sales
1.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HROW stock price
How has the Harrow Health stock price performed over time
Intraday
0.58%
1 week
13.85%
1 month
14.22%
1 year
69.5%
YTD
-12.04%
QTD
10.94%
Financial performance
How have Harrow Health's revenue and profit performed over time
Revenue
$212.86M
Gross profit
$158.64M
Operating income
$4.52M
Net income
-$21.7M
Gross margin
74.5%
Net margin
-10.2%
Harrow Health's operating income has soared by 159% YoY but it has decreased by 49% from the previous quarter
HROW's operating margin has surged by 138% year-on-year but it has dropped by 52% since the previous quarter
HROW's gross profit has soared by 64% YoY and by 6% QoQ
Harrow Health's net margin has soared by 55% YoY but it has decreased by 16% from the previous quarter
Price vs fundamentals
How does HROW's price correlate with its fundamentals
Growth
What is Harrow Health's growth rate over time
Valuation
What is Harrow Health stock price valuation
P/E
N/A
P/B
18.64
P/S
4.97
EV/EBIT
522.77
EV/EBITDA
66.83
EV/Sales
5.86
The EPS rose by 34% year-on-year but it has declined by 24% since the previous quarter
The stock's price to book (P/B) is 33% less than its 5-year quarterly average of 27.9
Harrow Health's equity has decreased by 19% from the previous quarter and by 7% YoY
HROW's revenue has surged by 53% year-on-year and by 7% since the previous quarter
HROW's P/S is 20% below its last 4 quarters average of 6.2 but 18% above its 5-year quarterly average of 4.2
Efficiency
How efficient is Harrow Health business performance
The ROIC has soared by 128% YoY but it has plunged by 54% from the previous quarter
The return on sales has surged by 118% year-on-year but it has dropped by 59% since the previous quarter
The return on assets is up by 46% year-on-year but it has declined by 17% since the previous quarter
Harrow Health's return on equity has increased by 34% YoY but it has decreased by 27% QoQ
Dividends
What is HROW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HROW.
Financial health
How did Harrow Health financials performed over time
The total assets is 18% greater than the total liabilities
Harrow Health's current ratio has shrunk by 70% YoY and by 56% QoQ
Harrow Health's quick ratio has plunged by 69% YoY and by 57% from the previous quarter
The debt to equity has grown by 29% YoY and by 24% from the previous quarter
Harrow Health's debt has increased by 20% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.